JPS5620588A - 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof - Google Patents

66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof

Info

Publication number
JPS5620588A
JPS5620588A JP10063780A JP10063780A JPS5620588A JP S5620588 A JPS5620588 A JP S5620588A JP 10063780 A JP10063780 A JP 10063780A JP 10063780 A JP10063780 A JP 10063780A JP S5620588 A JPS5620588 A JP S5620588A
Authority
JP
Japan
Prior art keywords
drug
derivative
manufacture
active component
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10063780A
Other languages
English (en)
Inventor
Edoson Damon Sekando Robaato
Naderuson Jiefurei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5620588A publication Critical patent/JPS5620588A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP10063780A 1979-07-25 1980-07-24 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof Pending JPS5620588A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6072979A 1979-07-25 1979-07-25

Publications (1)

Publication Number Publication Date
JPS5620588A true JPS5620588A (en) 1981-02-26

Family

ID=22031390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10063780A Pending JPS5620588A (en) 1979-07-25 1980-07-24 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof

Country Status (15)

Country Link
JP (1) JPS5620588A (ja)
AU (1) AU6072080A (ja)
BE (1) BE884407A (ja)
DE (1) DE3027619A1 (ja)
DK (1) DK318280A (ja)
ES (1) ES8105998A1 (ja)
FI (1) FI802318A7 (ja)
FR (1) FR2462438A1 (ja)
GB (1) GB2054593A (ja)
IL (1) IL60672A0 (ja)
IT (1) IT8049312A0 (ja)
NL (1) NL8004236A (ja)
PT (1) PT71592B (ja)
SE (1) SE8005303L (ja)
ZA (1) ZA804524B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011529931A (ja) * 2008-08-05 2011-12-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ４−ジメチルアミノ−フェニルで置換されているナフチリジン、及び医薬としてのその使用
US8912173B2 (en) 2011-07-26 2014-12-16 Boehringer Ingelheim International Gmbh Substituted quinolines and their use as medicaments
US8969568B2 (en) 2010-01-29 2015-03-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted naphthyridines and their use as medicaments

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502831A1 (de) * 1985-01-29 1986-07-31 Gödecke AG, 1000 Berlin 1,6-naphthyridinon-derivate, verfahren zu deren herstellung und deren verwendung
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
FR2751969B1 (fr) 1996-08-01 1998-12-04 Centre Nat Rech Scient Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702600A1 (de) * 1977-01-22 1978-07-27 Thomae Gmbh Dr K Neue aminoalkoxyphenyl-derivate

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011529931A (ja) * 2008-08-05 2011-12-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ４−ジメチルアミノ−フェニルで置換されているナフチリジン、及び医薬としてのその使用
US8957088B2 (en) 2008-08-05 2015-02-17 Boehringer Ingelheim International Gmbh 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
US8969568B2 (en) 2010-01-29 2015-03-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted naphthyridines and their use as medicaments
US9187478B2 (en) 2010-01-29 2015-11-17 Boehringer Ingellheim International GmbH Substituted naphthyridines and their use as medicaments
US8912173B2 (en) 2011-07-26 2014-12-16 Boehringer Ingelheim International Gmbh Substituted quinolines and their use as medicaments
US9199937B2 (en) 2011-07-26 2015-12-01 Boehringer Ingelheim International Gmbh Substituted quinolines and their use as medicaments

Also Published As

Publication number Publication date
FI802318A7 (fi) 1981-01-01
AU6072080A (en) 1981-01-29
SE8005303L (sv) 1981-01-26
ES493639A0 (es) 1981-07-01
ES8105998A1 (es) 1981-07-01
IT8049312A0 (it) 1980-07-24
PT71592B (en) 1981-08-11
DK318280A (da) 1981-01-26
NL8004236A (nl) 1981-01-27
PT71592A (en) 1980-08-01
IL60672A0 (en) 1980-09-16
ZA804524B (en) 1982-03-31
FR2462438A1 (fr) 1981-02-13
GB2054593A (en) 1981-02-18
BE884407A (fr) 1981-01-22
DE3027619A1 (de) 1981-02-19

Similar Documents

Publication Publication Date Title
JPS54148772A (en) Bisanthracycline compound*its manufacture and antiitumer drug containing it as main ingredient
JPS52114026A (en) Pharmaceutical composition having antiiinflammation activity
GB1546747A (en) Antibacterial pharmaceutical and feestuff compositions
PH13569A (en) Imidazolidine derivatives and pharmaceutical compositions containing the same
IL51450A (en) Cefuroxime esters,their preparation and pharmaceutical compositions containing them
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
JPS5625198A (en) Novel niccomycins* their manufacture and their use as insecticide
JPS55100313A (en) Drug composition and its manufacture
JPS5297921A (en) Aralkylaniline derivative* preparation thereof and medical composition containing same
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
JPS56161371A (en) Sulfonamide derivative, its manufacture and its use as drug
JPS5663946A (en) Phenylethylamine derivative* its manufacture and medicinal composition containing it as active component
JPS54112859A (en) Guanidine derivative*its manufacture and drug composition containing it
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
JPS5448776A (en) 2*44diaminopyrimidine derivative*its manufacture and medicine as active component
IL60892A (en) Triophosphonate derivatives and their use as insecticides and nematocides
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
JPS5620588A (en) 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof
JPS5634668A (en) Tetrahydroqunoline derivative* its manufacture and antiarrhythmic as active component thereof
JPS56131509A (en) Agricultural drug and manufacture
JPS5344566A (en) Novle tertialybutyllsubstituted pyrazolylcarbamate*its preparation and insecicidal or nematocidal composition containing same as active ingredient
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
JPS5320433A (en) Pharmaceutical composition and application